Clinical Trials Browser

Phase 1 × Tyrosine Kinase Inhibitors × 90 days × Clear all

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Neoplasms, Recurrence

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Clinical Trials